Patient-Reported Outcomes After Breast Biopsy

Recruiting in Palo Alto (17 mi)

+5 other locations

Age: 18+

Sex: Female

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: Dana-Farber Cancer Institute

No Placebo Group

Trial Summary

What is the purpose of this trial?This trial looks at how women feel after a breast biopsy, focusing on those with certain breast conditions. The goal is to help women and doctors make better care decisions based on these experiences.

Eligibility Criteria

This trial is for adults who've had a breast biopsy showing atypical lesions and have been treated at certain study sites. They must be able to read English or Spanish, provide consent, and have at least one year of follow-up data post-diagnosis. Those with other cancers within the last five years or invasive breast cancer ever are excluded.

Inclusion Criteria

I was treated for early breast changes at a specified hospital.

Able to read either English or Spanish and able to provide written (via paper), or on-line informed consent

I was 18 or older when my condition was first diagnosed.

+3 more

Exclusion Criteria

I have been diagnosed with invasive or microinvasive breast cancer before.

I have not been diagnosed with any cancer other than non-melanoma skin cancer in the last 5 years.

Patients identified by treating physician as being unsuitable for contact

+1 more

Participant Groups

The PORTAL study is not testing a drug but rather collecting information through surveys on how patients feel physically and emotionally after treatment for specific non-invasive breast conditions like ADH, ALH, LCIS, or DCIS.

1Treatment groups

Experimental Treatment

Group I: Patient-reported Outcomes SurveyExperimental Treatment1 Intervention

The survey will administered online, over the phone, or via mail.